Platelet Refractoriness: Examining Associated Morbidity and Mortality

Area of Science:

• Hematology
• Oncology Nursing
• Transfusion Medicine

Background:

• Platelet refractoriness is the inadequate response to platelet transfusions.
• It leads to bleeding complications, prolonged hospitalization, and reduced survival rates.
• Oncology nurses are key in managing this critical issue.

Purpose of the Study:

• To highlight the significance of platelet refractoriness in clinical settings.
• To emphasize the role of oncology nurses in managing platelet refractoriness.
• To underscore the importance of evidence-based strategies.

Main Methods:

• This abstract focuses on the clinical definition and implications of platelet refractoriness.
• It reviews the impact of refractoriness on patient outcomes.
• It discusses the essential role of nursing interventions.

Main Results:

• Platelet refractoriness is a major clinical challenge with severe consequences.
• Effective management can mitigate associated risks.
• Nurses' early detection and intervention are crucial.

Conclusions:

• Platelet refractoriness necessitates vigilant monitoring and prompt management.
• Oncology nurses are integral to improving patient outcomes by addressing refractoriness.
• Evidence-based practices are essential for limiting morbidity and mortality.